Virtual Medicinal Product (VMP)
-
Caplacizumab 10mg powder and solvent for solution for injection vials
Name Details
Current Name
Caplacizumab 10mg powder and solvent for solution for injection vials
|
Start Date
03-10-2019
|
End Date
|
|
Abbreviated Name
Caplacizumab 10mg inj vials
|
Start Date
03-10-2019
|
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous, Subcutaneous
- Form
- Powder and solvent for solution for injection
- Ontology Form/Route
- solutioninjection.intravenous, solutioninjection.subcutaneous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
B01AX07
SNOMED Codes
Code
|
Start Date
|
End Date
|
37761911000001109 |
03-10-2019 |
|
VMP Ingredients
VMP ingredients table
Caplacizumab |
Based on Ingredient Substance |
|
10 mg |
|
Name
Caplacizumab
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
10.0
Strength and UOM (Dmr)
Parent Products
-
VTM
Caplacizumab
-
VMP
(Current) Caplacizumab 10mg powder and solvent...
Virtual Medicinal Product Pack (VMPP) Information